Stemtech adds Darryl Green and Benjamin Kaplan to its Board of Directors

– USA, FL –  Stemtech Corporation (OTC: GNTW), a leading nutraceutical company and a pioneer in the field of stem cell nutrition, today announced the appointments of Darryl Green and Benjamin Kaplan to its Board of Directors, bringing the total number of Directors to five.

“We are proud to welcome Darryl Green and Benjamin Kaplan to the Board,” said Chairman and CEO, Charles Arnold. “Both Darryl and Ben were early investors in Stemtech, and add tremendous value to the team. Darryl Green’s extensive, in-depth background in senior executive roles in the health, wellness and supplements industry is a strategic asset to the Company that we believe will assist us in successfully scaling our operations.”

About Darryl Green

Mr. Green is a 30-year veteran of the health, wellness, and supplements industry with deep domain expertise, and served as President of Domestic and International Franchising for GNC Holdings, Inc. He spent more than 30 years with GNC, which included 20 years of corporate and franchise executive positions, and over 10 years of various field positions, encompassing all facets of retail operations across the United States. In 2011, he was part of the team that led the number one IPO of the year, helping the company to raise $360 Million. Mr. Green played an instrumental role in driving GNC Holdings Inc. from a market cap of $1 Billion to over $3.7 Billion. He helped grow the global franchise business to over 3000 locations in 53 countries, which led GNC Franchising to be the 7th most desirable franchise in the world.

About Benjamin Kaplan

Mr. Kaplan has been a successful entrepreneur and investor for over 20 years, with a particular focus on health, wellness and pharmaceutical companies. He currently serves as the CEO of Ehave, Inc., a leader in digital therapeutics delivering evidence-based therapeutic interventions to patients.

About Stemtech Corporation

Stemtech Corporation, a leading nutraceutical company with a direct sales distribution model, was founded on April 18, 2018, after acquiring the operations from its predecessor Stemtech International, Inc. which was founded in 2005. From 2010 through 2015, Stemtech International, Inc., was recognized four separate times on the Inc. 5000 Fastest-Growing Companies list. In 2018, the Company underwent an extensive executive reorganization, and continued operations under new leadership. Stemtech specializes in creating products and formulas that are patent protected in the U.S. and select international markets. The Company’s patented formulas help the release, circulation, and migration of the body’s adult stem cells from its bone marrow. The Company markets its products under the following brands: RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem (Oral Health Care), and D-Fuze. Its products are all-natural and plant-based and manufactured under cGMP under the auspices of the Dietary Supplemental Health and Education Act.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team